The Tool Desk
Outbyte Driver Updater FREEFix the driver behind crashes, sound loss and screen glitchesFind Drivers →Outbyte PC Repair FREERepair Windows errors before they cause bigger problemsFix Now →In December 2025, 23 bipartisan U.S. senators asked Agriculture Secretary Brooke Rollins to finalize a science-based plan for a livestock bird flu vaccine. As of the most recent USDA Animal and Plant Health Inspection Service (APHIS) program page, USDA has not authorized any HPAI vaccine for use in poultry. The one exception is case-by-case use in certain endangered or zoo species. This update explains what the senators requested, what USDA has published since, and why a poultry vaccine raises trade questions that go beyond disease control.
What the senators asked USDA to do
Reuters reported on December 11, 2025, that the letter was led by Sen. Amy Klobuchar of Minnesota and Sen. Mike Rounds of South Dakota. It asked USDA to take four specific steps:
- Finalize a vaccine strategy. The senators urged the department to complete a science-based livestock bird flu vaccine plan rather than leave it at the exploratory stage.
- Consult animal-health stakeholders and industry experts. The letter stated: “Any finalized vaccine strategy must take into account feedback from animal health stakeholders, industry experts, and be grounded in sound science.”
- Assess trade consequences. The senators asked USDA to account for how a vaccination program could affect international trade.
- Work with trading partners and affected producers. The letter asked USDA to engage both groups on managing those effects.
The request is a December 2025 letter as reported by Reuters, republished by Investing.com. It is not a Senate vote or a new 2026 action, and the reporting does not show a formal reply from USDA.
Timeline of USDA poultry vaccine activity
| Date | What happened | Source |
|---|---|---|
| March 20, 2025 | USDA said it was exploring whether poultry vaccination is viable and that no vaccine use had been authorized. | USDA APHIS announcement |
| June 2025 | USDA announced it was developing a possible poultry vaccination plan. Reuters reported that details had not been released. | Reuters, as republished by Investing.com |
| December 11, 2025 | Reuters reported the 23-senator letter to Secretary Rollins. | Reuters, as republished by Investing.com |
| February 2, 2026 | APHIS updated its poultry HPAI response page, describing a five-pronged approach and public input on vaccines and therapeutics. | USDA APHIS, “HPAI in Poultry” |
| May 31, 2026 | APHIS updated its HPAI Poultry Innovation Grand Challenge page, reporting funded projects and the current authorization status. | USDA APHIS, “HPAI Poultry Innovation Grand Challenge” |
Where USDA stands now
- Authorization. The May 31, 2026 APHIS page states: “No HPAI vaccine has been authorized for use at this time, except on a case-by-case basis in certain endangered or zoo species.” No poultry vaccine is approved for routine flock use.
- Funding. APHIS says it has invested $100 million in selected projects covering prevention, therapeutics, vaccine development, transmission research, and biosecurity. Projects were selected competitively in consultation with the U.S. Department of Health and Human Services. Recipients include vaccine manufacturers, universities, producer organizations, and other research partners. Funding is research investment, not authorization.
- Stakeholder process. APHIS says it is soliciting public input and holding biweekly discussions with governors, state agriculture departments, state veterinarians, and poultry and dairy farmers. Topics include vaccine and therapeutics strategy, logistics, and surveillance.
- Original criteria. In its March 2025 announcement, USDA listed the qualities it would weigh for any candidate: matching circulating virus clades, distinguishing vaccinated from infected animals (DIVA), compatibility with serologic testing, longer-lasting immunity, hands-off delivery, and safety and efficacy.
The sources reviewed do not establish whether USDA has shared a finalized vaccination plan with trading partners since the December 2025 letter. Check the APHIS Grand Challenge page for later changes, because authorization status is the fact most likely to shift.
#1 Best Overall
- FDA Authorized 15-Minute Flu A&B, COVID Test Kit: Over-the-counter flu and COVID test for home use with rapid results in just 15 minutes.
- Made for Ages 2 and Above; Parents Can Stop Guessing: Quickly identify whether you or your kids are dealing with coronavirus or influenza A & B. Adult-collection is required for those aged 2-13 years, and self-collection by individuals aged 14 years and older.
- Same Ease-of-Use; Get 3 Results in 1 Test: Utilizing the familiar 4 user-friendly steps of at-home COVID tests, you can now get all 3 results for COVID-19 and Flu A & B at once with 5 drops of sample.
- Fast and Convenient COVID and Flu Tests for Home: Use this COVID and influenza rapid test kit in the comfort of your home. Bypass the need for a doctor's visit and protect your loved ones from potential exposure to contagious illnesses at school, work, or public gatherings.
- Compact Design for On-the-Go Testing: Stay safe wherever you go with our COVID-19, Flu A & B 3-in-1 self-test. Its compact design ensures easy storage and convenient portability for your travel bag.
Why a vaccine raises trade questions
Reuters reported that the poultry industry is divided on vaccination, largely because trading partners could restrict exports. The concern is practical. A vaccinated flock can complicate how an importing country verifies disease status, so a vaccine program has to be designed with that verification in mind. This is why DIVA capability and compatibility with serologic testing appear among USDA’s criteria.
The reporting does not quantify the possible loss of trade, and it does not name which countries might impose restrictions. Any estimate of market effects would be speculation based on the sources available here.
Rank #2
- FDA Authorized 15-Minute Flu A&B, COVID Test Kit: Over-the-counter flu and COVID test for home use with rapid results in just 15 minutes.
- Made for Ages 2 and Above; Parents Can Stop Guessing: Quickly identify whether you or your kids are dealing with coronavirus or influenza A & B. Adult-collection is required for those aged 2-13 years, and self-collection by individuals aged 14 years and older.
- Same Ease-of-Use; Get 3 Results in 1 Test: Utilizing the familiar 4 user-friendly steps of at-home COVID tests, you can now get all 3 results for COVID-19 and Flu A & B at once with 5 drops of sample.
- Fast and Convenient COVID and Flu Tests for Home: Use this COVID and influenza rapid test kit in the comfort of your home. Bypass the need for a doctor's visit and protect your loved ones from potential exposure to contagious illnesses at school, work, or public gatherings.
- Compact Design for On-the-Go Testing: Stay safe wherever you go with our COVID-19, Flu A & B 3-in-1 self-test. Its compact design ensures easy storage and convenient portability for your travel bag.
Why USDA is not relying on vaccines alone
APHIS describes biosecurity as key to protecting poultry flocks. Its approach includes voluntary biosecurity assessments and audits, with cost sharing for high-risk fixes, alongside vaccine and therapeutic research. Vaccination is one tool among several, not the department’s only current intervention.
What the outbreak has cost so far
Reuters reported in December 2025 that more than 180 million chickens, turkeys, and other poultry had been killed because of the outbreak that began in 2022. That is a cumulative figure as of the report, not a current total.
Rank #3
- 3-In-1 Flu A B And COVID-19 Test Kit: Designed to check for multiple respiratory targets in one test, allowing users to complete a single test instead of using separate kits at home.
- Simple At-Home Testing Process: Step-by-step format with nasal swab, buffer tube, and test cassette designed for straightforward use during everyday situations when testing is needed.
- Quick Results In About 10 Minutes: Provides results in a short timeframe, making it a convenient Covid home test to use before travel, or gatherings.
- Designed For Family Use Ages 2 And Up: Suitable for a wide range of users, including adults and children, making it a practical option for shared household use.
- Compact Single-Test Kit For On-Demand Use: The portable design on these covid tests allows for easy storage in a drawer, bag, or travel kit for quick access when needed.
What this means for consumers
No authorized poultry bird flu vaccine is available for purchase or use in commercial flocks, so a household cannot act on vaccination today. The sources reviewed here do not connect a vaccination decision to retail egg or poultry prices, so this article does not estimate any household cost effect. Readers tracking food budgets should watch for an APHIS authorization change and for any trade announcement, since either could affect supply and pricing.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.What is and is not established
- The senators’ letter, its signatories, and its requests are documented in Reuters reporting from December 11, 2025. The details come from a letter that Reuters said it had seen.
- Current authorization status and funding come from APHIS pages last modified February 2, 2026 and May 31, 2026.
- No comparative efficacy data for individual vaccine candidates appears in the sources, so this article does not rank them.
- Whether a vaccine strategy will be finalized, and on what timeline, is not established.
The March 2025 USDA statement remains useful for the criteria it set, but the May 2026 APHIS page is the current source for authorization status.
Quick Recap
Best Value
- 3-In-1 Flu A B And COVID-19 Test Kit: Designed to check for multiple respiratory targets in one test, allowing users to complete a single test instead of using separate kits at home.
- Simple At-Home Testing Process: Step-by-step format with nasal swab, buffer tube, and test cassette designed for straightforward use during everyday situations when testing is needed.
- Quick Results In About 10 Minutes: Provides results in a short timeframe, making it a convenient Covid home test to use before travel, or gatherings.
- Designed For Family Use Ages 2 And Up: Suitable for a wide range of users, including adults and children, making it a practical option for shared household use.
- Compact Single-Test Kit For On-Demand Use: The portable design on these covid tests allows for easy storage in a drawer, bag, or travel kit for quick access when needed.
Rank #4
- EXTENDED SHELF LIFE | CHECK YOUR CURRENT EXPIRATION DATE - The WELLlife Flu A&B Home Test has a 16-month shelf life extension. The expiration date printed on the package may reflect the original date. Scan the QR code and enter the LOT number to verify the current expiration date before use
- FLU A & B DETECTION | ONE TEST FOR TWO INFLUENZA TYPES - Detect Influenza A and Influenza B using anterior nasal swab samples. This over-the-counter test provides a convenient way to check for both influenza types with one test
- RESULTS IN 10 MINUTES | QUICKLY READ YOUR TEST - Results are available in just 10 minutes. Follow the Instructions for Use to perform the test correctly and interpret the results
- 5 TESTS | MULTIPLE TESTS IN ONE PACKAGE - Includes 5 individually packaged tests, providing multiple testing opportunities in one package. A practical option when testing may be needed at different times
- STEP-BY-STEP INSTRUCTIONS | NO SPECIAL EQUIPMENT NEEDED - Follow the included instructions through sample collection, testing, and result interpretation. The testing process requires no special equipment or laboratory setup
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
